Discover key takeaways from Bruker Corporation's Q4 2024 earnings call, highlighting strong diagnostics, semiconductor growth, and confident 2025 ...
Hosted on MSN1d
Bruker’s (NASDAQ:BRKR) Q4 Sales Top Estimates But Full-Year Sales Guidance Misses ExpectationsScientific instrument company Bruker (NASDAQ:BRKR). reported Q4 CY2024 results , with sales up 14.6% year on year to $979.6 ...
BILLERICA, Mass. - Bruker Corporation (NASDAQ:BRKR) reported fourth-quarter earnings that surpassed analyst expectations, while also providing a 2025 outlook largely in line with Wall Street estimates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback